[PDF][PDF] NOACs 用药教育对心房颤动患者抗凝认知水平的影响
李浩， 施芳红， 顾智淳， 沈珑， 张顺国， 刘晓琰 - 世界临床药物, 2019 - jwph.com.cn
… strategy for non-vitamin K antagonist oral anticoagulant drugs (… the cognitive level about
anticoagulation of patients with atrial … review, network meta-analysis, and cost effectiveness …
anticoagulation of patients with atrial … review, network meta-analysis, and cost effectiveness …
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… recommend direct oral anticoagulants (DOACs) over vitamin K antagonists (… K拮抗剂口服
抗凝药物(non-vitamin K antagonist oral anticoagulants, NOACs),也称新型口服抗凝药(novel oral …
抗凝药物(non-vitamin K antagonist oral anticoagulants, NOACs),也称新型口服抗凝药(novel oral …
基于Granada‑II 分类法评价达比加群酯在住院患者中存在的药物相关问题.
陈倩倩， 张斌， 李扬 - Practical Pharmacy & Clinical …, 2024 - search.ebscohost.com
… Cost-effectiveness analysis of non-vitamin K antagonist oral anticoagulants versus warfarin
… Nonvitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis[J].J …
… Nonvitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis[J].J …
[PDF][PDF] 2019 台灣腦中風學會非維他命K 拮抗劑口服抗凝血劑用於心房纖維顫動患者中風預防治療指引
林雅如， 黃英庭， 崔百青， 蔡力凱， 鍾芷萍， 郭書帆… - 台灣中風醫誌, 2019 - stroke.org.tw
… 有鑑於四種非維他命K拮抗劑口服抗凝血 劑(non-vitamin K antagonist oral anticoagulants,
NOACs)上市以來,陸續有相當多新的醫學實 證資料發表,故有本次更新.主要更新原2016 指引第四章…
NOACs)上市以來,陸續有相當多新的醫學實 證資料發表,故有本次更新.主要更新原2016 指引第四章…
膝关节置换过程中应用不同抗凝药物: 血液流变学指标的变化
胡勇， 彭丹， 沈毅， 陈夏 - 中国组织工程研究, 2015 - cjter.com
… review of cost-effectiveness analyses of novel oral … of direct or non-vitamin k antagonist oral
anticoagulants: a practical … dose adjustment of non-vitamin k antagonist oral anticoagulants? …
anticoagulants: a practical … dose adjustment of non-vitamin k antagonist oral anticoagulants? …
非瓣膜性房颤防治综合策略中左心耳封堵术的助攻
兰贝蒂， 王瑞涛， 谢学刚， 张玉顺 - 心脏杂志, 2021 - heartj.cn
… Non-vitamin K antagonist … cost effectiveness following stroke reduction strategies in AF:
warfarin versus NOACs versus LAA closure[J]. J Am Coll Cardiol, 2015, 66(24): 2728 – 2739. …
warfarin versus NOACs versus LAA closure[J]. J Am Coll Cardiol, 2015, 66(24): 2728 – 2739. …
可穿戴/移动设备在隐匿性心房颤动管理中的应用进展和挑战
高晨曦， 陈德芳， 陈清勇， 沈灿， 廖晓阳 - 中国全科医学, 2024 - chinagp.net
… this article,we review the clinical outcomes,cost-effectiveness,… nonvitamin K antagonist oral
anticoagulants versus warfarin … Costeffectiveness of population screening for atrial fibrillation:…
anticoagulants versus warfarin … Costeffectiveness of population screening for atrial fibrillation:…
[PDF][PDF] 脑卒中预防与药物研发应用
王陇德 - PROGRESS IN PHARMACEUTICAL SCIENCES, 2019 - pps.cpu.edu.cn
… review, network meta-analysis and costeffectiveness analysis[J]. … non-vitamin K antagonist
oral anticoagulants versus warfarin … heart disease: a systematic review and meta-analysis[J]. J …
oral anticoagulants versus warfarin … heart disease: a systematic review and meta-analysis[J]. J …
利伐沙班联合硫酸氢氯吡格雷在老年急性冠脉综合征合并非瓣膜性心房颤动患者PCI 术后的应用效果和安全性.
钱丹丹， 吴军， 崔杨慧 - Evaluation & Analysis of Drug-Use in …, 2023 - search.ebscohost.com
… Cost-effectiveness of radial access … safety of non-vitamin K antagonist oral anticoagulants
in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study[J]. …
in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study[J]. …